Transcription factor ASCL1 targets SLC6A13 to inhibit the progression of hepatocellular carcinoma via the glycine-inflammasome signaling. Biomol Biomed [Internet]. 2024 May 21 [cited 2024 Jun. 30];. Available from: https://bjbms.org/ojs/index.php/bjbms/article/view/10328